Clinical Trial: Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.

Study Status: Completed
Recruit Status: Completed
Study Type: Observational




Official Title: Biomarkers for Angiogenesis in Renal Cell Carcinoma and Neuro-endocrine Tumours.

Brief Summary: The primary objective of this study is to analyse the concentration dopamine and serotonin in thrombocytes of patients with renal cell carcinoma and neuro-endocrine tumours compared to the concentrations of these catecholamines in healthy volunteers. The concentration dopamine and serotonin in thrombocytes with and without medication will also be evaluated.